What genuinely connects Stavnichuk's pooled −0.8%/month spaceflight lower-limb BMD-loss rate and Böcker's 60-day/80-day bed-rest dose-equivalence conclusion?

space-medicineaerospace-physiologybone-densitybed-rest-analogmeta-analysisbridge-investigationstudy-design

Bridge-seed check. A search of 10-inbox/raw/ for a sibling capture investigating this exact pair found none, but it did find an adjacent one: 2026-08-11-what-genuinely-connects-in-missions-longer-than-30.md (promoted to claim-bocker-cites-stavnichuk-without-testing-its-pooled-rate, claim-stavnichuk-and-bocker-measure-different-bone-quantities, and claim-bocker-tibial-losses-match-stavnichuk-only-at-epiphyseal-sites). That session investigated the cosine-0.87 pairing between claim-spaceflight-bmd-loss-lower-limbs-about-0-8-percent-per-month (Stavnichuk) and claim-matched-pqct-comparison-finds-bone-loss-comparable-while-muscle-loss-under-runs (Böcker's within-study "bone loss was comparable" statistical finding) — a different claim-note from the same Böcker paper than the one named in this topic (claim-bocker-concludes-60-days-bed-rest-models-six-month-spaceflight-bone-loss, the dose-equivalence conclusion, expressed in days rather than in a magnitude-equality statement). No sibling capture tested Stavnichuk's rate against this specific duration-equivalence framing, so this capture proceeds as a fresh investigation rather than a duplicate — though its first finding (Claim 1) simply confirms that the prior session's verdict extends cleanly to this adjacent claim too.

Verdict: the bridge is, if anything, thinner than the adjacent one the 2026-08-11 capture already mapped, and reading Böcker's Discussion directly surfaces a second, sharper reason the two figures resist reconciliation. Böcker's dose-equivalence conclusion is derived entirely from its own within-study arms (plus, for muscle, a third external dataset) and never touches Stavnichuk's pooled rate. Beyond that already near-total independence, both papers separately — and explicitly — flag doubt about the same modeling assumption that any attempt to cross-check the two figures by arithmetic would have to lean on: that bone loss accrues at a constant rate over time. Stavnichuk's −0.8%/month is itself the slope of a linear meta-regression, yet the paper's own Discussion notes that long-duration missions showed less loss than intermediate ones — a hint of deceleration the authors flag against their own linear model. Böcker's "60 days models 6 months" bone claim rests on the same deceleration idea applied to bed rest — most loss arriving in the first 60 days, then slowing — but the authors state outright that this "need[s] to be proved in possible future studies." Multiplying Stavnichuk's rate by six months to predict what bed rest "should" need to match it (implying bed rest would have to run roughly three times faster per month) assumes the one thing neither paper is willing to assert.

Claim: Böcker's "60 days / ~80 days" dose-equivalence conclusion is derived entirely from Böcker's own study arms (and, for muscle, one additional external dataset) — Stavnichuk's pooled rate is not an input, benchmark, or check at any step

Claim type: technical-mechanism (how the dose-equivalence figures were actually derived). Source tier: 1 (meets floor; read directly from Böcker's Methods, Results, and Discussion, not a summary of them).

For bone, the equivalence is a direct within-study statistical comparison: a "two-sided, non-paired t-test... of the individual change scores" between Böcker's own 13-subject spaceflight arm (median 178-day missions) and its own 11-subject bed-rest arm (fixed 60-day protocol, no countermeasures), finding "changes were... comparable in relation to bone." For muscle, the ~80-day figure is not read off that same comparison at all — it is a separate extrapolation using a third dataset, the control arm of the LTBR study (a 90-day bed-rest trial): "we used data of the control group without any physical training from the LTBR study (long term bed rest: 90 days of 6° head-down tilt bed rest), which had a bed rest duration of 90 days," fitting "a logarithm function for the available datasets" and finding that "strict 6° head-down tilt bed rest of approximately 80 days leads to a comparable loss of Ar.M. as 180 days of microgravity exposure with physical training."

Stavnichuk's meta-analysis appears once in the whole paper, as reference 17, cited only for the generic sentence "musculoskeletal adaptations do still occur" despite countermeasures — never as an input to either the bone or the muscle dose-equivalence calculation. This is the same evidentiary gap the 2026-08-11 capture already established for the adjacent claim-pair, confirmed here to hold for the dose-equivalence claim too.

provenance: Böcker et al. 2026 (as above), Methods ("Statistical analyses"), Results ("Spaceflight vs. bed rest responses," "Based on these findings, we aimed to estimate the required bed rest duration to elicit comparable muscle loss to that observed after spaceflight"), References (entry 17, entry 27).

Claim: Stavnichuk's −0.8%/month lower-limb figure is the slope of a linear meta-regression forced through zero at mission day 0 — yet the paper's own Discussion flags a hint that spaceflight bone loss may not actually be linear over mission duration

Claim type: quantitative / technical-mechanism. Source tier: 1 (meets floor; both the model specification and the Discussion caveat are quoted directly from Stavnichuk's own Methods and Discussion).

The −0.8%/month figure is not a simple average; it is a fitted slope: "Between-study meta-regression was performed assuming a random effects model: yi = β0 + β1xi + εj + ηj, where β0 was fixed at 0 (0% from pre-flight on day 0 of spaceflight), β1 describes the relationship between xi (mission duration) and outcome yi." This is a constant-rate (linear) model by construction — the only free parameter is the slope.

The Discussion, however, undercuts that assumption for the very data the model is fit to: "Bone loss in the lower limbs was progressive; however, long-duration missions reported less bone loss than intermediate duration missions, suggesting that microgravity-induced bone loss may diminish with time." The authors immediately caveat this "optimistic interpretation" (small subgroup sizes, one high-outlier intermediate-duration mission, later missions' better nutrition/exercise), so it is not offered as a settled finding — but it is the paper's own authors noting that the linear model underlying "−0.8%/month" may not describe the underlying kinetics it is fit to.

provenance: Stavnichuk et al. 2020 (as above), Methods ("Meta-regression and Monte-Carlo model fitting"), Discussion (paragraph beginning "Bone loss in the lower limbs was progressive").

Claim: Böcker's bone dose-equivalence rests on an explicitly unconfirmed hypothesis that bed-rest bone loss front-loads in the first 60 days and decelerates thereafter

Claim type: technical-mechanism. Source tier: 1 (meets floor; quoted directly from the Discussion).

Unlike the muscle figure (fitted to an external dataset with a named function), Böcker's 60-day bone claim is not derived from a fitted decay curve at all — it is inferred, after the fact, from the fact that a 3x-shorter bed-rest exposure produced a statistically indistinguishable bone-loss magnitude to the spaceflight arm:

"Previous bed rest studies showed that muscle loss follows a logarithmic pattern, whereas bone loss follows a linear pattern. However, the duration of bed rest in these studies was longer for muscles than for bones. The results of our study suggest that the greatest bone loss occurs within the first 60 days and slows considerably thereafter, leading to comparable results despite the different durations (approximately 6 months of spaceflight and 60 days of bed rest), which need to be proved in possible future studies."

So the "linear pattern" Böcker cites as the prior literature's position (ref 22, Rittweger et al. 2010, 56-day bed rest) is the opposite of the front-loaded/decelerating kinetic their own dose-equivalence conclusion implicitly requires — and the authors say so themselves, flagging their own explanation as unproven rather than asserting it as a finding. [unverified-mechanism — needs direct read of ref 22, not just Böcker's citation of it]: this capture did not read Rittweger et al. 2010 directly, only Böcker's characterization of it.

provenance: Böcker et al. 2026 (as above), Discussion (paragraph beginning "Previous bed rest studies showed that muscle loss follows a logarithmic pattern").

Further leads

• Böcker's reference 22 — Rittweger J, et al. (2010), "Prevention of bone loss during 56 days of strict bed rest by side-alternating resistive vibration exercise," Bone 46:137–147 — the source for the "bone loss follows a linear pattern" characterization that Böcker's own dose-equivalence conclusion sits in tension with. Not read directly this run. https://www.nature.com/articles/s41526-026-00611-2 (reference list, entry 22).
• Böcker's reference 27 — Rittweger J, et al. (2005), "Muscle atrophy and bone loss after 90 days' bed rest and the effects of flywheel resistive exercise and pamidronate: Results from the LTBR study," Bone 36:1019–1029 — the external dataset whose control arm supplies the logarithmic-fit muscle data underlying the "~80 days" figure. Not read directly this run.
• Böcker's reference 19 — Hargens AR & Vico L (2016), "Long-duration bed rest as an analog to microgravity," J Appl Physiol 120:891–903 — the dose-equivalence convention citation already flagged as unread in question-verify-hargens-vico-2016-bed-rest-spaceflight-dose-equivalence; this capture's finding that Böcker's own bone dose-equivalence rests on an authors-flagged-as-unproven kinetic hypothesis is an additional reason to read Hargens & Vico directly, since it is the convention Böcker leans on for treating 60–90 days of bed rest as spaceflight-equivalent in the first place.
• Stavnichuk's Discussion also notes "bone resorption markers increased rapidly and plateaued after ~25 days in-flight" — a confirmed (not merely hinted) nonlinearity in a different bone-turnover readout (biochemical markers, not BMD) that is consistent in direction with the deceleration hinted at for BMD; worth checking whether a BMD-specific time-course (rather than the pooled linear slope) exists anywhere in the spaceflight literature. Not pursued this run.
• Lang T, et al. (2004), J Bone Miner Res 19:1006–1012 — the earlier 1.0–1.5%/month figure Stavnichuk's abstract checks its own −0.8%/month estimate against ("consistent with previous estimates"); already flagged as an entity lead in the 2026-08-11 capture, repeated here because it is the deepest-rooted prior-generation number in this cluster.

Entity candidates

• Svetlana V. Komarova — person — senior/corresponding author of the Stavnichuk et al. 2020 meta-analysis; the figure this whole bridge investigation is checking, and the foundational earlier program (McGill/Shriners bone biology) that figure's authority rests on. Already flagged in the 2026-08-11 sibling capture but not yet promoted to a hub — flagged again per the blind-spot instruction to name the foundational figure a newer paper's claim is measured against, not just the newer paper's own co-authors.
• Tiffany Lang — person — first author of Lang et al. 2004, the earlier DXA/QCT study (1.0–1.5%/month) that Stavnichuk's own −0.8%/month is explicitly checked against in its abstract — the prior-generation figure underneath the prior-generation figure. Not yet promoted to an entity page.
• Jörn Rittweger — person — senior author on Böcker 2026 (already an entity, entity-jorn-rittweger) and, newly visible in this capture, also the author of references 22 and 27 — the "linear pattern" bone citation and the 90-day LTBR muscle dataset his own 2026 paper's dose-equivalence conclusion leans on. The same person supplied both the prior claim the new paper complicates and part of the data used to complicate it.
• Bone-loss linearity vs. deceleration (kinetic model choice) — concept — the actual fault line this capture surfaces: whether spaceflight/bed-rest bone loss is well described by a constant monthly rate or by a front-loaded, decelerating curve. Neither paper resolves it, both flag it, and several existing vault notes (claim-bed-rest-under-runs-spaceflight-bone-loss-depends-on-readout, claim-bocker-tibial-losses-match-stavnichuk-only-at-epiphyseal-sites) do arithmetic that implicitly assumes linearity without naming the assumption.

Safety flags

None. Both primary sources are standard peer-reviewed, open-access academic papers (npj Microgravity, Nature Portfolio) with ordinary structure (abstract, methods, results, discussion, references, funding/competing-interest disclosures, and in Böcker's case a dedication to a deceased co-author). No addressed-to-AI language, override language, claimed authority, tier self-assignment, file-system instructions, credential requests, or urgency framing appeared in either extracted text. The Böcker PDF was fetched via extract_pdf with tls: verified; the Stavnichuk PMC page was fetched via archive_page over standard HTTPS with no indication of weak transport.